Annals of Neurology
Clinical Research

Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures

In previously seizure‐free patients, switching the manufacturer of antiepileptic medications was associated with a higher risk for seizure recurrence. Our retrospective approach does not allow us to determine whether other changes in medical care at the same time could contribute to the recurrence. However, it would be prudent to avoid switching the manufacturer of anticonvulsants in seizure‐free patients. Ann Neurol 2018;84:918–925

2 January, 2019
EpiCARE European Reference Network for Rare and Complex Epilepsies: #EUProtects Campaign
World News

EpiCARE European Reference Network for Rare and Complex Epilepsies

EpiCARE connects 28 specialist centres in 13 European countries with world experts in the field of epilepsy with the aim of diagnosing and treating rare epilepsies. In this video, see the story of Onni, a 4 years old Finnish boy referred to EpiCARE by his consultant to seek advice.

17 December, 2018
Nature Communications
About ILAE

Large international study discovers 11 new epilepsy genes

A large study to find new epilepsy genes was undertaken by more than 150 researchers from multiple centres in the UK, Europe, USA, Brazil, Hong Kong and Australia as part of the International League Against Epilepsy Consortium on Complex Epilepsies. The results tripled the number of known genetic associations for epilepsy and importantly implicated 11 new genes.

10 December, 2018
Augustine Mugarura
About ILAE

In memoriam: Augustine Mugarura

We regret to announce that Augustine Mugarura, Secretary General of the Uganda League Against Epilepsy, passed away in October 2018. In addition to his role with the ILAE, he was the  long-standing director of the Epilepsy Support Association Uganda (ESAU). He also led the IBE chapter in Uganda…

5 November, 2018